RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Monash IVF Group Equity 2024

Monash IVF Group Equity

273.2 M AUD

Monash IVF Group Dividend yield

4.4 %

Ticker

MVF.AX

ISIN

AU000000MVF3

WKN

A116LZ

In 2024, Monash IVF Group's equity was 273.2 M AUD, a 1.97% increase from the 267.92 M AUD equity in the previous year.

Monash IVF Group Aktienanalyse

What does Monash IVF Group do?

The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Monash IVF Group's Equity

Monash IVF Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Monash IVF Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Monash IVF Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Monash IVF Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Monash IVF Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Monash IVF Group Stock

What is the equity of Monash IVF Group this year?

Monash IVF Group has equity of 273.2 M AUD this year.

What was the equity of Monash IVF Group compared to the previous year?

The equity of Monash IVF Group has increased/decreased by 1.97% increased compared to the previous year.

What impact does a high equity have on investors of Monash IVF Group?

A high equity is advantageous for investors of Monash IVF Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Monash IVF Group?

A low equity can be a risk for investors of Monash IVF Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Monash IVF Group affect the company?

An increase in equity of Monash IVF Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Monash IVF Group affect the company?

A reduction in equity of Monash IVF Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Monash IVF Group?

Some factors that can affect the equity of Monash IVF Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Monash IVF Group so important for investors?

The equity of Monash IVF Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Monash IVF Group take to change the equity?

To change equity, Monash IVF Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Monash IVF Group pay?

Over the past 12 months, Monash IVF Group paid a dividend of 0.06 AUD . This corresponds to a dividend yield of about 4.4 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.06 AUD.

What is the dividend yield of Monash IVF Group?

The current dividend yield of Monash IVF Group is 4.4 %.

When does Monash IVF Group pay dividends?

Monash IVF Group pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Monash IVF Group?

Monash IVF Group paid dividends every year for the past 13 years.

What is the dividend of Monash IVF Group?

For the upcoming 12 months, dividends amounting to 0.06 AUD are expected. This corresponds to a dividend yield of 4.36 %.

In which sector is Monash IVF Group located?

Monash IVF Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Monash IVF Group from 4/5/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Monash IVF Group pay the last dividend?

The last dividend was paid out on 4/5/2024.

What was the dividend of Monash IVF Group in the year 2023?

In the year 2023, Monash IVF Group distributed 0.063 AUD as dividends.

In which currency does Monash IVF Group pay out the dividend?

The dividends of Monash IVF Group are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Monash IVF Group

Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.